
    
      The project aims to study protein turnover in glioblastoma using mass spectrometry after
      13C-valine incorporation. This will allow to identify proteins in circulation secreted by
      tumor which could be diagnostic and pronostic biomarkers in patients With High-grade Glioma.
    
  